Don't want ads? Subscribe or login now.

Fresenius Targets Nostrum's Generic PhosLo GelCaps

By Megan Leonhardt · January 17, 2012, 2:44 PM EST

Fresenius Medical Care Holdings Inc. on Friday lodged a patent infringement suit in Massachusetts federal court in an effort to block Nostrum Laboratories Inc. from marketing a generic version of kidney...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Fresenius Medical Care Holdings, Inc. v. Nostrum Laboratories, Inc.

Case Number

1:12-cv-10083

Court

Massachusetts

Nature of Suit

Patent

Date Filed

January 13, 2012

Recent Articles By Megan

November 01, 2012
Catholic-Owned Co. Gains Shield From ACA Contraception Rule
August 30, 2012
Gentiva Clinicians Denied Class Cert. In OT Lawsuit
August 23, 2012
Pfizer, Others Shake Price-Fixing Appeal From Pharmacies
August 21, 2012
6th Circ. Tosses Nurse's Lunch Pay Suit As Time-Barred
July 27, 2012
Doctors Accuse Blue Cross Of Anti-Competitive Scheme
July 03, 2012
SAP, Ariba Send More Info On $4.3B Merger To DOJ
June 08, 2012
Georgia Medical System Hit With $200M Suit Over Data Theft
May 24, 2012
Stericycle Must Shed Recently Bought Rival, UK Regulator Says
May 18, 2012
Va. Joins $500M Medicaid Fraud Suit Against Healthpoint
April 17, 2012
Hospitals To Pay $1.6M To Settle Nurses' Antitrust Suit